ARO Annual Meeting (February 2013)
“Pharmacological activators and inhibitors of Kv3.1 potassium currents” (Brown et al.).
Publications
Tweets
Autifony CEO Charles Large will be speaking at the a webinar ‘Fragile X syndrome – in pursuit of a cure’ World Frag… https://t.co/DPw8f5LPMN
We are currently recruiting for a Senior Electrophysiologist who will be based in Padova Italy, please apply by sen… https://t.co/QL4GySZbKH
RT @Instinctif_HLS:Great to see this exciting new collaboration between @AutifonyLtd and @Boehringer announced! https://t.co/Cx8LI319if
Comments are closed.